{"id":"W2615945276","doi":"10.6004/jnccn.2017.0075","title":"Immunotherapies for Lung Cancer","year":2017,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Pembrolizumab; Atezolizumab; Medicine; Nivolumab; Immunotherapy; Oncology; Lung cancer; PD-L1; Internal medicine; Standard of care; First line; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002139145,0.0001328048,0.0003128018,0.00004467275,0.0006159762,0.00007115821,0.0004091598,0.00006645426,0.0001686231],"category_scores_gemma":[0.00008459971,0.00008346921,0.0004502632,0.00007997764,0.0001695419,0.0001416601,0.00004696861,0.0002221994,3.21542e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003906796,"about_ca_system_score_gemma":0.0005644602,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005222513,"about_ca_topic_score_gemma":0.00002322125,"domain_scores_codex":[0.9987934,0.00003260928,0.0003758393,0.0001075341,0.0004968089,0.0001937711],"domain_scores_gemma":[0.9967802,0.0001609857,0.0009642253,0.0001955733,0.001849506,0.00004955309],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01823409,0.0001451283,0.05644983,0.0002832175,0.006248046,0.000006633563,0.0005145452,0.01445693,0.02980771,0.0009032011,0.8330523,0.03989835],"study_design_scores_gemma":[0.007411141,0.0002097789,0.4297114,0.001556847,0.0003837741,0.0001047342,0.00005100599,0.001689461,0.001879563,0.001509122,0.5552757,0.0002174612],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5109482,0.3373842,0.001053383,0.1217864,0.02375754,0.002376489,0.0002383228,0.00003542925,0.002420097],"genre_scores_gemma":[0.9674984,0.007274316,0.001208465,0.01237522,0.009038585,0.0000831769,0.000002150422,0.00004420622,0.00247548],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4565502,"threshold_uncertainty_score":0.4737653,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05760166304265469,"score_gpt":0.3876294147813151,"score_spread":0.3300277517386604,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}